Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Q-Line Biotech Limited (NSE: QLINE), ISIN INE1G2W01011 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
QLINE last traded at ₹601.75 (-0.50%), with a 52-week range of ₹431.00 to ₹735.00 (as of 13 Oct 2026).
Shareholding as of Jun 2026: promoters 67.51%, FIIs 1.67%, DIIs 10.14%, mutual funds 1.59%.
EquiSense Score (ECS): 66/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.